Velcro-CD47 already proved its ability to enhance macrophage phagocytosis of tumor cells in vitro and to target the monocyte subpopulation specifically, and its putative anticancer efficacy will be further evaluated in pre-clinical models. This evidence concerns the gene CD47 and neoplasm.